bioRxivImmunologyPreprint
SARS-CoV-2 escapes CD8 T cell surveillance via mutations in MHC-I restricted epitopes
B. Agerer, M. Koblischke, V. Gudipati, M. Smyth, A. Popa, J.-W. Genger, L. Endler, D. M. Florian, V. Muehlgrabner, A. Lercher, P. Gattinger, R. Torralba-Gombau, T. Penz, I. Fae, S. Wenda, M. Traungott, G. Walder, G. Fischer, W. Hoepler, E. Pawelka, A. Zoufaly, R. Valenta, C. Bock, J. B. Huppa, J. H. Aberle, A. Bergthaler
Abstract
CD8+ T cell immunity to SARS-CoV-2 has been implicated in COVID-19 severity and virus control, though direct evidence has been lacking so far. Here, we identified non-synonymous mutations in MHC-I restricted CD8+ T cell epitopes after deep sequencing of 747 SARS-CoV- 2 virus isolates. Mutant peptides exhibited diminished or abrogated MHC-I binding, which was associated with a loss of recognition and functional responses by CD8+ T cells isolated from HLA-matched COVID-19 patients. Our findings highlight the capacity of SARS-CoV-2 to subvert CD8+ T cell surveillance through escape mutations in MHCI-restricted viral epitopes. This provides evolutionary evidence for CD8+ T cell immunity controlling SARS-CoV-2 with consequences for COVID-19 vaccine design.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response
C. Xiao, L. Mao, … G. Chen·iSciencePeer-reviewed·Mar 1, 2022
- In silico analysis predicts a limited impact of SARS-CoV-2 variants on CD8 T cell recognition
O. I. Isaeva, S. L. C. Ketelaars, P. Kvistborg·bioRxiv·Mar 23, 2022
- High resolution profiling of MHC-II peptide presentation capacity, by Mammalian Epitope Display, reveals SARS-CoV-2 targets for CD4 T cells and mechanisms of immune-escape
F. J. Obermair, F. Renoux, … J. Kisielow·bioRxiv·Mar 2, 2021
- Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals
A. Redd, A. Nardin, … A. A. Tobian·bioRxiv·Dec 6, 2021
- Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations
- SARS-CoV-2 Omicron subvariants evolved to promote further escape from MHC-I recognition
M. Moriyama, C. Lucas, … A. Iwasaki·bioRxiv·May 4, 2022